Most Cited & Viewed

Most Cited & Viewed Papers

Citations Article
 
Integrative Statistics, Machine Learning and Artificial Intelligence Neural Network Analysis Correlated CSF1R with the Prognosis of Diffuse Large B-Cell Lymphoma
 
Barriers and Facilitators of Use of Hydroxyurea among Children with Sickle Cell Disease: Experiences of Stakeholders in Tanzania
 
SARS-CoV-2 and Autoimmune Cytopenia
 
Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis
 
CAR-T Cell Therapy for the Treatment of ALL: Eradication Conditions and In Silico Experimentation
 
Burkitt Lymphoma Incidence in Five Continents
 
Why Immunotherapy Fails in Multiple Myeloma
 
KSHV/HHV8-Associated Lymphoproliferative Disorders: Lessons Learnt from People Living with HIV
 
Persisting Endothelial Cell Activation and Hypercoagulability after COVID-19 Recovery—The Prospective Observational ROADMAP-Post COVID-19 Study
 
Primary Cutaneous B-Cell Lymphoma: An Update on Pathologic and Molecular Features
Views Article
Sickle Cell Disease, a Review
What’s New in the Classification, Diagnosis and Therapy of Myeloid Leukemias
Why Immunotherapy Fails in Multiple Myeloma
Peripheral T-Cell Lymphomas of the T Follicular Helper Type: Clinical, Pathological, and Genetic Attributes
Cold Agglutinin Disease: A Distinct Clonal B-Cell Lymphoproliferative Disorder of the Bone Marrow
Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis
Diffuse Large B-Cell Lymphoma: Recognition of Markers for Targeted Therapy
Pathophysiology of Myelodysplastic Syndromes
Future Developments in the Treatment of AL Amyloidosis
Cold Agglutinin Disease: Improved Understanding of Pathogenesis Helps Define Targets for Therapy
Downloads Article
Inflammatory and Immune Disorders Associated with Myelodysplastic Syndromes
Why Immunotherapy Fails in Multiple Myeloma
Sickle Cell Disease, a Review
The Next Step for MRD in Myeloma? Treating MRD Relapse after First Line Treatment in the REMNANT Study
Impaired Hematopoiesis after Allogeneic Hematopoietic Stem Cell Transplantation: Its Pathogenesis and Potential Treatments
Treatment of Lower Risk Myelodysplastic Syndromes
Measurable Residual Disease Assessment in Multiple Myeloma: How Deep Is Enough?
The Management of Hematologic Patients with Bloodstream Infections Due to Multi-Drug Resistant Bacteria: Where Do We Stand? From Antibacterial Prophylaxis to the Treatment of Septic Shock
Future Developments in the Treatment of AL Amyloidosis
Current Status of CAR-T Cell Therapy in Multiple Myeloma
Back to TopTop